Report Overview
The Global Hyaluronic Acid Market is forecast to grow at a CAGR of 7.0%, reaching USD 16.40 billion in 2031 from USD 11.70 billion in 2026.
Hyaluronic acid (HA) is naturally available in the human body. In the eyes and joints, HA is found in the highest concentrations. The substance has the ability to keep skin plump and moist. Hence, it is utilized by many cosmetic surgeons in the form of injectables to reduce aging on the skin.
The growing global geriatric population is projected to drive the market growth during the forecast period. The presence of companies offering advanced hyaluronic acid solutions for customers worldwide is further augmenting the market growth during the forecast period. Hyaluronic acid can be found in the form of serums, sheet masks, and dermal fillers. Popular brand names for hyaluronic acid fillers include Juvederm, Elevess, Puragen, and Captique, among others. The growing adoption of minimally invasive procedures for cosmetic procedures is further propelling the market growth during the forecast period.
Hyaluronic Acid Market Drivers:
The soaring dermal filler procedures worldwide are augmenting the growth of the global hyaluronic acid market during the forecast period.
The market is projected to soar with the growing number of dermal filler procedures in the world. There is an increasing interest among consumers to look young, and thus, this has surged the demand for cosmetic procedures that include hyaluronic acid dermal filler consumption, further propelling the market demand during the forecast period. The dermal fillers help in filling wrinkles and are utilized to add volume to the soft tissues, thus giving them a full and voluptuous look. These gel injections are inserted in different areas of the body, including the lips, cheeks, and jawline.
Other factors fueling the demand for dermal filler procedures include the immediate effects observed after application. This reduces the signs of aging and provides consumers with near-instant satisfaction. The currently growing selfie trend and uploading it on social media platforms have raised the growth prospects of these procedures. Consumers seek measures that make them look beautiful while posting pictures on social media platforms. The increasing aging worldwide is further augmenting the market growth, demanding dermal filler procedures during the forecast period. The total population 65 years of age and above is predicted to surge from 55,11,19,375 in 2012 to 69,79,67,728 in 2019 (source: The World Bank).
The increasing interest of men to look their best, apart from women, is further adding to the surging demand for dermal fillers, propagating the market growth during the forecast period. These groups of people are quite comfortable with the available aesthetic procedures, offering innovative options to enhance their looks. Additionally, the convenient methods to administer hyaluronic acid into the human skin are further propelling the market demand owing to the consumer-friendliness of the cosmetic procedures that are minimally invasive and are least painful, offering huge gains.
With the increasing disposable income worldwide, especially in the developing regions of the world, the demand for dermal fillers is continuing to grow. This is mainly attributed to increasing consumer spending ability, further offering them options to look above their basic expenditures and hence, are willing to spend on sophisticated cosmetic procedures. According to the National Bureau of Statistics Data, the per capita consumer spending in China rose to 21,559 yuan in 2019, an increase of 5.5% y-o-y.
There is a wide availability of dermal fillers in the market, which include temporary, permanent, and semi-permanent fillers. Most of the non-permanent fillers are safer to use and are FDA-approved; these include hyaluronic-based fillers as well.
The presence of companies offering innovative hyaluronic acid-based products is fueling the market growth during the forecast period.
Galderma, focused on offering science-based solutions for skin health through its Restylane® brand, offers a diverse range of hyaluronic-acid-based commodities segregated into two product groups, namely, Restylane fillers and Restylane Skinboosters.
The fillers category is a combination of two unique technologies involving OBT and NASHTA™. These have further established safety profiles for more than two decades of experience and offer high patient satisfaction with around 40 million treatments worldwide. The product portfolio includes Restylane Fynesse™, Restylane Refyne™, Restylane, and Restylane Volyme™ for the restoration of a youthful appearance that includes filling fine lines and wrinkles and replacing the lost fullness and volume due to aging. Restylane Defyne™, Restylane Lyft™, and Restylane Kysse™ are used for enhancing the appearance for the creation of harmony and balance, and for the enhancement of the shape, contour, and definition.
The Skinboosters category offers solutions for skin rejuvenation, delivering hydration and skin imperfection improvement, thus leading to radiant and healthy skin.
Humedix Co., Ltd. offers hyaluronic acid as the active pharmaceutical ingredient for applications in eye drops, ophthalmology injections, beauty fillers, and osteoarthritis drugs.
Kewpie Corporation offers hyaluronic acid for cosmetic applications. Products include HAbooster™, Hyalo-Oligo®, Hyaloveil®-P, and Hyalorepair®. The HAbooster is a collagen cycle accelerator, hyaluronic acid, a novel product having a super low molecular weight of around 2000. Further promoting the collagen cycle and increasing skin moisture. The low molecular weight hyaluronic acid, Hyalo-oligo, has an average molecular weight of less than 10,000. It soaks into the skin's hard layer and imparts moisture from inside the skin. Hyaloveli-P is a hyaluronic acid containing adsorptive properties that stay in hair and on the skin even when rinsed with water. Hence, this contributes to sustained moisture even after the washing off of the hyaluronic acid. Hyalorepair is a lamellar structure, reviving hyaluronic acid that contains the properties of hydrophilic and hydrophobic groups. This further contributed to enhancing and reviving the skin’s barrier functionality, further resulting in smoother skin.
Hyaluronic Acid Market Geographical Outlook:
On the basis of geography, the market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific region. North America is projected to hold a significant market share owing to the early adoption of technologies and innovation. Additionally, the substantial aging population, along with increasing susceptibility to age-associated diseases like osteoarthritis, is further contributing to fueling the market demand during the forecast period. The Asia Pacific region is estimated to account for a substantial market share owing to the increasing interest in the adoption of anti-aging products.
Hyaluronic Acid Market Developments:
May 2026: Evolus announced the commercial European launch of Estyme® injectable hyaluronic acid gels, expanding its global dermal filler portfolio with four HA products targeting facial volumizing and aesthetic treatments.
March 2026: Galderma launched Restylane® Defyne™ and Refyne™ in Japan, introducing the country’s first OBT™ hyaluronic acid injectables designed for natural facial movement and wrinkle correction applications.
March 2026: Merz Aesthetics received EU approval for two new BELOTERO® Balance indications covering infraorbital hollow and forehead line treatments, expanding approved hyaluronic acid dermal filler applications in Europe.
January 2026: Revance Therapeutics and Teoxane received FDA approval for RHA® Dynamic Volume, a hyaluronic acid filler developed for cheek augmentation and age-related midface contour deficiency correction.
September 2025: Waldencast announced FDA approval of Obagi® saypha® MagIQ™ injectable hyaluronic acid gel, expanding Obagi Medical into the U.S. dermal filler and medical aesthetics market.
Hyaluronic Acid Market Scope:
| Report Metric | Details |
|---|---|
| Total Market Size in 2026 | USD 11.70 billion |
| Total Market Size in 2031 | USD 16.40 billion |
| Forecast Unit | Billion |
| Growth Rate | 7.0% |
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Segmentation | Application, End-users, Geography |
| Geographical Segmentation | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies |
|
Hyaluronic Acid Market Segmentation:
By Application
Tissue Engineering
Osteoarthritis Treatment
Dermal Filler
Others
By End-Users
Pharmaceutical Industry
Cosmetic Surgery Centers
Dermatology Clinics
Others
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others
Market Segmentation
By Application
By End-users
By Geography
Table of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL HYALURONIC ACID MARKET BY APPLICATION
5.1. Introduction
5.2. Tissue Engineering
5.3. Osteoarthritis Treatment
5.4. Dermal Filler
5.5. Others
6. GLOBAL HYALURONIC ACID MARKET BY END-USERS
6.1. Introduction
6.2. Pharmaceutical Industry
6.3. Cosmetic Surgery Centers
6.4. Dermatology Clinics
6.5. Others
7. GLOBAL HYALURONIC ACID MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. United Kingdom
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Allergan (AbbVie Inc.)
9.2. Sanofi
9.3. Seikagaku Corporation
9.4. Contipro a.s.
9.5. BioScience GmbH
9.6. Kewpie Corporation
9.7. Bohus BioTech AB
9.8. Humedix.Co.Ltd
9.9. Anika Therapeutics, Inc.
9.10. Laboratoires Vivacy, S.A.S.
9.11. Cosmedica Skincare
9.12. Wellona Pharma
9.13. Plamed Green Science Group
9.14. Revitajal (Beauty Aesthetic Finland Oy)
9.15. Altergon Italy Srl
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES
Global Hyaluronic Acid Market Report
Trusted by the world's leading organizations











